🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of Tylenol, asserting the corporations hid safety concerns that the drug presented to pediatric neurological development.

The lawsuit comes four weeks after President Donald Trump publicized an unproven link between consuming Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which previously sold the medication, the only pain reliever approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he said they "deceived the public by gaining financially from pain and promoting medication ignoring the potential hazards."

Kenvue states there is no credible evidence linking Tylenol to autism.

"These corporations misled for generations, deliberately risking numerous people to boost earnings," Paxton, from the Republican party, stated.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the safety of acetaminophen and the possible consequences that could have on the welfare of women and children in America."

On its online platform, the company also said it had "consistently assessed the relevant science and there is lacking reliable evidence that indicates a verified association between consuming paracetamol and autism."

Organizations acting on behalf of medical professionals and medical practitioners share this view.

The leading OB-GYN organization has said paracetamol - the main ingredient in acetaminophen - is a restricted selection for pregnant women to treat discomfort and elevated temperature, which can present serious health risks if left untreated.

"In multiple decades of investigation on the use of paracetamol in gestation, zero credible investigations has successfully concluded that the usage of paracetamol in any trimester of gestation results in neurodevelopmental disorders in offspring," the association stated.

The lawsuit cites latest statements from the previous government in arguing the drug is allegedly unsafe.

Recently, the former president raised alarms from public health officials when he told expectant mothers to "resist strongly" not to consume acetaminophen when sick.

The FDA then released a statement that doctors should think about restricting the consumption of acetaminophen, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in children has not been proven.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in spring to undertake "extensive scientific investigation" that would identify the source of autism spectrum disorder in a matter of months.

But authorities cautioned that finding a unique factor of autism spectrum disorder - thought by researchers to be the consequence of a complicated interplay of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a form of enduring cognitive variation and condition that impacts how persons encounter and interact with the world, and is recognized using doctors' observations.

In his court filing, the attorney general - a Trump ally who is running for the Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the science" around paracetamol and autism.

The lawsuit attempts to require the firms "eliminate any promotional materials" that asserts Tylenol is safe for pregnant women.

The court case mirrors the concerns of a assembly of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in recently.

A federal judge dismissed the legal action, declaring investigations from the family's specialists was lacking definitive proof.